SINCLAIR PHARMA ANNOUNCES NEW BOARD APPOINTMENT AND SENIOR MANAGEMENT CHANGE

Sinclair Pharma (“Sinclair”, www.sinclairpharma.com) a global aesthetics company headquartered in London and fully-owned subsidiary of Huadong Medicine Company Limited announces that Chris Spooner is stepping down as CEO to be replaced by Miguel Pardos, who will also join the board of Sinclair. Alan Olby, former CFO will also be leaving the company.


Read More

Sinclair Pharma Announces Exclusive Product License and Worldwide Distribution Agreement for Préime DermaFacial with EMA Aesthetics Limited for all territories outside the UK and Germany

Sinclair Pharma (“Sinclair”, www.sinclairpharma.com) a global aesthetics company headquartered in London and fully-owned subsidiary of Huadong Medicine Company Limited announces that it has signed an exclusive product license and worldwide distribution agreement for Préime DermaFacial from EMA Aesthetics Limited for all territories outside the UK and Germany for an initial 5 year period.


Read More

Sinclair Pharma Announces Acquisition of Viora Boosting its Energy-Based Devices (EBD) Portfolio and Gaining Direct Commercial Base in the United States

Sinclair Pharma (“Sinclair”, www.sinclairpharma.com) a global aesthetics company headquartered in London and fully-owned subsidiary of Huadong Medicine Company Limited announces the acquisition of the group of companies that form the Viora group (“Viora” or the “Company”,
www.vioramed.com ).


Read More

Sinclair Pharma Announces Acquisition of Cocoon Medical and Expansion into Energy-Based Devices (EBD)

Sinclair Pharma (“Sinclair”, www.sinclairpharma.com) a global aesthetics company headquartered in London and fully-owned subsidiary of Huadong Medicine Company Limited announces the acquisition of the group of companies forming the Cocoon Medical business (“Cocoon”, www.cocoonmedical.com).


Read More